Welcome to Quantum
Quantum Molecular Pharmaceuticals, Inc. (Quantum), a majority-held subsidiary of Imagin Diagnostic Centres, Inc. (IMAGIN) was formed to capitalize on lack of availability of the facilities required to manufacture the pharmaceuticals used for Positron Emission Tomography (PET). There is very limited availability of the infrastructure which is required as part of the process to commercially manufacture, the Positron Emitting Radiopharmaceutical (PER) 18F-Fluoro-deoxy-glucose (FDG), the most common compound used for PET scans. Quantum plans to build and operate cyclotrons in many major markets across Canada.